Mustafa Munye

Director R&D Operations • Complement Therapeutics

Mustafa Munye, Ph.D has 10+ years in the discovery and development of ATMP’s. He has led process and analytical development for AAV gene therapies, CAR-T and PSC-derived cell therapies to support first-in-human studies. Mustafa is currently director of R&D Operations at Complement Therapeutics whose lead program is an AAV gene therapy.

Also speaking

Martin Murphy

Chief Executive Officer • Syncona Investment

Joanna Norman

Senior Staff Scientist VGT • FUJIFILM Diosynth Biotechnologies

Sanjin Zvonic

Vice President Business Development and Practice Expert • Dark Horse Consulting

Event Info


2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.